(SAVA) Cassava Sciences - Performance -92.1% in 12m
Compare SAVA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-63.07%
#114 in Group
Rel. Strength
0.89%
#7886 in Universe
Total Return 12m
-92.12%
#182 in Group
Total Return 5y
-82.37%
#127 in Group
P/E -
(?) Percentile in Group
P/E Forward 152
90th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: SAVA (-92.1%) vs XLV (-4.1%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: SAVA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for SAVA
Total Return (including Dividends) | SAVA | XLV | S&P 500 |
---|---|---|---|
1 Month | 42.86% | 0.87% | 13.81% |
3 Months | -26.72% | -7.96% | -6.30% |
12 Months | -92.12% | -4.06% | 10.65% |
5 Years | -82.37% | 43.49% | 107.77% |
Trend Score (consistency of price movement) | SAVA | XLV | S&P 500 |
1 Month | 73.1% | -8.1% | 83% |
3 Months | -63.1% | -75.3% | -75.3% |
12 Months | -70.1% | -28.8% | 50.1% |
5 Years | -25.1% | 89.7% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #31 | 41.6% | 25.5% |
3 Month | #163 | -20.4% | -21.8% |
12 Month | #183 | -91.8% | -92.9% |
5 Years | #132 | -87.7% | -91.5% |
FAQs
Does SAVA Cassava Sciences outperforms the market?
No,
over the last 12 months SAVA made -92.12%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months SAVA made -26.72%, while XLV made -7.96%.
Over the last 3 months SAVA made -26.72%, while XLV made -7.96%.
Performance Comparison SAVA vs Indeces and Sectors
SAVA vs. Indices SAVA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.76% | 29.1% | -88.8% | -103% |
US NASDAQ 100 | QQQ | 3.57% | 25.5% | -89.0% | -104% |
US Dow Jones Industrial 30 | DIA | 3.35% | 32.9% | -88.5% | -99.8% |
German DAX 40 | DAX | 3.78% | 27.9% | -115% | -118% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.58% | 31.0% | -89.5% | -99.5% |
Hongkong Hang Seng | HSI | 0.59% | 22.9% | -97.1% | -106% |
India NIFTY 50 | INDA | 8.68% | 38.0% | -89.2% | -91.9% |
Brasil Bovespa | EWZ | 2.71% | 25.6% | -97.5% | -83.8% |
SAVA vs. Sectors SAVA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.12% | 29.5% | -95.8% | -114% |
Consumer Discretionary | XLY | 3.38% | 28.6% | -87.8% | -106% |
Consumer Staples | XLP | 4.62% | 36.3% | -95.7% | -101% |
Energy | XLE | 3.94% | 36.1% | -82.2% | -82.7% |
Financial | XLF | 2.66% | 29.3% | -95.9% | -115% |
Health Care | XLV | 6.77% | 42.0% | -83.8% | -88.1% |
Industrial | XLI | 2.07% | 26.0% | -90.2% | -103% |
Materials | XLB | 3.96% | 29.3% | -83.9% | -86.9% |
Real Estate | XLRE | 5.08% | 31.3% | -89.5% | -108% |
Technology | XLK | 2.68% | 21.6% | -85.9% | -99.2% |
Utilities | XLU | 3.71% | 33.3% | -96.4% | -110% |
Aerospace & Defense | XAR | 1.78% | 21.7% | -100% | -119% |
Biotech | XBI | 10.4% | 31.1% | -68.6% | -79.8% |
Homebuilder | XHB | 3.29% | 31.4% | -75.6% | -84.6% |
Retail | XRT | 1.86% | 28.2% | -84.5% | -90.6% |